USD
  • GBP GBP
  • CNY CNY
  • EUR EUR
  • INR INR
  • JPY JPY
  • MYR MYR
  • ZAR ZAR
  • KRW KRW
  • THB THB
Frost & Sullivan Frost & Sullivan
  • ABOUT US
  • CONTACT US
  • SIGN IN
  • REGISTER
  • PARTNER LOGIN
    • CDS.frost.com
    • Member.frost.com
  • USD
    • GBP GBP
    • CNY CNY
    • EUR EUR
    • INR INR
    • JPY JPY
    • MYR MYR
    • ZAR ZAR
    • KRW KRW
    • THB THB
  • INDUSTRIES
    • Aerospace, Defence and Security
      Aerospace Systems
      • Air Traffic Management (ATM)
      Airlines & Airports
      Space
      Security
      • Mass Transportation Security
      Defence
      • C4ISR

      Explore more Categories

    • Automotive
      Automotive
      • Aftermarket
      • Automotive IoT
      • Business Strategy and Innovation
      • Chassis, Safety & Autonomous
      • Connected Car
      • Commercial Vehicle Telematics
      • Fleet and Leasing
      • New Mobility
      • On-Road and Offroad Commercial Vehicles
      • Powertrain

      Explore more Categories

    • Transportation and Logistics
      Transportation and Logistics
      • Logistics Infrastructure
      • Freight Transportation
      • Storage and Warehousing
      • Freight Forwarding
      • Contract Logistics
      Rail
      • Information Systems
      • Infrastructure
      • Rolling Stock
      • Passenger Transportation
      • Freight Transportation

      Explore more Categories

    • Chemicals and Materials
    • Food and Agriculture
    • Electronics and Sensors
      Electronics and Sensors
      • Semiconductor
      • Electronic Devices
      • Sensors & Instrumentation
      • Instrumentation
      • Communications Test

      Explore more Categories

    • Energy
      Energy
      • Oil & Gas
      • Power Generation
      • Critical Power
      • Grids
      • Energy Storage
      • Distributed Energy
      • Others

      Explore more Categories

    • Environment
      Water
      • Water Utilities & Smart Solutions
      • Industrial Water Services
      Homes and Buildings
      • Energy Management
      • Smart Buildings
      • Smart Cities
      • Connected Living
      Waste Management
      • Waste to Value

      Explore more Categories

    • Healthcare
      Life Sciences
      • Clinical Diagnostics and Research Tools
      • Pharmaceuticals and Biotech
      Healthcare
      • Medical Imaging & Informatics
      • Advanced Medical Technologies
      • Digital Health

      Explore more Categories

    • Industrial Automation
      Automation
      • Industrial Hardware
      • Industrial Software
      • Industrial
      • Welding
      Process Control
      • Pumps
      • Valves
      • Compressors
      Power Transmission
      • Electric Drives
      • Motion Controllers
      • Electric Motors
      • Mechanical Components
      Fluid Automation
      • Pnuematic Equipment
      • Hydraulic Equipment

      Explore more Categories

    • Test and Measurement Instrumentation
      Test and Measurement Instrumentation
      • Electronic Measurement
      • Analytical Instrumentation
      • Condition Monitoring
      • Nondestructive Testing
      • Dimensional Metrology

      Explore more Categories

    • Information Technology
      Information Technology
      • Authentication
      • Network Security
      • IT Services and Applications
      • Contact Centers
      • Kiosks and Retail Systems

      Explore more Categories

    • Telecom
      Unified Communications and Collaboration (UCC)
      • Communications Endpoints
      • Communications CPE Services
      • Enterprise Communications Software
      • Hybrid Architectures
      • Networking and Communications Infrastructure
      • Premises-based Systems
      Telecom
      • Mobile and Wireless Communications
      • Communications Services
      • Enterprise Communications
      • Satellite Communications

      Explore more Categories

    • Entertainment and Media
      Entertainment and Media
      • Digital Media
      • Media
      • Advertising
      • Broadcast Television
      • Cinema
      • OTT Video and TV Everywhere
      • Pay TV (Cable, DTH, IPTV)

      Explore more Categories

    • Metals and Minerals
    • Personal Protective Equipment
    • Macroeconomics
      Macroeconomics
      • Country Profile
      • Economic Outlook
      • Economic Tracker

      Explore more Categories

  • THEMES
    AI

    Artificial Intelligence - AI

    Artificial Intelligence involves the science and engineering of developing intelligent machines

    iiot

    Industrial Internet of things - IIOT

    The manufacturing world is at a cusp of a new revolution that will redefine conventional business models

    IOT

    Internet of things - IOT

    IoT will have a major impact on businesses and consumers in the future

    BigDATA

    Big Data and Analytics

    The world is creating 2.5 exabytes of data daily

    Cloud

    Cloud Computing

    Our research seeks to connect-the-dots across multiple trends

    Robotics

    Robotics

    Personal Robots are Set to Be a $19 Billion Market

    Brexit

    Brexit Analysis

    Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies

    Femtech

    Femtech Market Research

    Time for a Digital Revolution in the Women’s Health Market

  • SERVICES
    Services

    Industry Research Database - iFrost

    iFrost is a digital platform for interactive and dynamic reporting of data.

    Subscription - Industry Research

    The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products

  • CART
  • Home
  • The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors
loading please wait

The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors

The Next Generation of Cancer Therapies

Frost & Sullivan
6000.0000 USD https://store.frost.com/the-global-immuno-oncology-therapeutics-market-checkpoint-inhibitors.html
RELEASE DATE
04-Jul-2016
REGION
North America
Research Code: MBA0-01-00-00-00
SKU: HC02672-NA-MR_18851
Request Sample

USD 8,000.00

USD 6,000.00 save 25 %

* Required Fields

USD 8,000.00

USD 6,000.00 save 25 %

Pay by invoice

ENQUIRE NOW
  • Description
  • Table of Contents
  • Request Sample

Description

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibitors in the drug classes CTLA-4, PD-1/PD-L1, LAG-3, and TIM-3, identifying companies and products in development, dollars spent at each phase (preclinical through launch), cost and reimbursement implications to payers, challenges to commercialization, and opportunities for pharmaceutical, biotech, or diagnostic companies as oncology treatment algorithms evolve. The study period is 2011 to 2020.

Table of Contents

Executive Summary—Checkpoint Inhibitors

Scope and Segmentation

Key Questions this Study will Answer

Key Takeaways

Market Snapshot

Market Snapshot (continued)

8 Big Market Themes for Checkpoint Inhibitors

A Vibrant Ecosystem

Paradigm Expansion to Solid Tumor Cancer Therapies

Regional Launch Highlights

Game-changing Companies

Significant Investor Funding

Key 2016 Predictions—Checkpoint Inhibitor Market

Disruptive Pipeline Analysis

Key Methodology and Scope

Checkpoint Inhibitor Drug Classes

Timeline of Checkpoint Product Approvals

Competitive Landscape—Target Segments, Count of Marketed and Pipeline Products

Checkpoint Segmentation by Subtype

Competitive Landscape—Target Product Counts by Phase

Competitive Landscape

Checkpoint Pipelines by Company, Target, and Phase

Checkpoint Pipelines by Company, Target, and Phase (continued)

Checkpoint Pipelines by Company, Target, and Phase (continued)

Checkpoint Pipelines by Company, Target, and Phase (continued)

Checkpoint Target Segmentation

Competitive Landscape—CTLA-4/CAIX/GITR Segment, Products in Development

Competitive Landscape—PD-1/PD-L1 (programmed death 1-receptor)

Competitive Landscape—LAG-3 (lymphocyte activating gene 3)

Competitive Landscape—TIM-3 (T-cell immunoglobin and mucin domain 3)

Product Dashboards of Leading Checkpoint Inhibitors

PD-1 Product Dashboard—Keytruda® (Pembrolizumab): Merck & Co. (Marketed)

PD-1 Product Dashboard—Opdivo® (Nivolumab): Bristol-Myers Squibb/Ono (Marketed)

CTLA-4 Product Dashboard—Yervoy® (ipilimumab): Bristol-Myers Squibb (Marketed)

PD-L1 Product Dashboard—Tecentriq® (Atezolizumab): Roche (Marketed)

Key Companies and Products to Watch by Target

Competitive Overview of Established Companies

Checkpoint Inhibitors—PD-1/PD-L1

PD-L1 Product Dashboard—Avelumab (MSB0010718C): Merck KGaA (Phase III)

PD-L1 Product Dashboard—Durvalumab (MEDI-4736): AstraZeneca / MedImmune (Phase III)

Checkpoint Inhibitors—CTLA-4

CTLA-4 Product Dashboard—Tremelimumab (MEDI-1123): AstraZeneca (Phase III)

Opportunities in Combination Therapies

Immuno-oncology Combination Therapies

Checkpoint Combination Clinical Trials by Indication

Immuno-oncology Checkpoint Phase III Trials to Watch

Immuno-oncology Checkpoint Phase III Trials To Watch (continued)

Disruptive Technologies and Advances in this Field

Commercialization Analysis

Market Opportunities

Potential Game-changing Therapies

Overall Environmental Impact Factors

Checkpoint Product Patent Expirations

Commercialization Analysis—Biomarkers

Biomarker Challenges

Commercialization Analysis—Cost Considerations

Opportunities in this Market—Escalating Drug Costs

Checkpoint Inhibitor Payer Environment

J-Codes, Annual Costs, and US Payers

Reimbursement Pathway—On-label Reimbursement Path

Reimbursement Pathway—Off-Label, Medicare

Reimbursement Pathway—Off-Label, Commercial Payers

Reimbursement Pathway—Off-Label, Commercial Payers (continued)

A Snapshot of Global Drug Price Control Methods

Pitfalls to Avoid

Commercialization Analysis—Key Companies and Products to Watch

Companies to Watch

Companies to Watch (continued)

Checkpoint Inhibitor Forecast Sales Total—2020 ($20.5B)Actual Sales by Product

Commercialization Analysis—Funding Considerations

Investors Pour in Significant Funds

Checkpoint Milestones

2015 Deal and Financing—CTLA-4 Receptor Gene Therapy

2015 Deal and Financing Summary—PD-1/PD-L1

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—PD-1/PD-L1 (continued)

2015 Deal and Financing Summary—LAG-3

2015 Deal and Financing Summary—LAG-3 (continued)

2015 Deal and Financing Summary—LAG-3 (continued)

2015 Deal and Financing Summary—TIM-3

Conclusion and Take Home Points

Key Conclusions

Growth Opportunities in 4 Checkpoint Inhibitor Segments

New Market Opportunities—Checkpoint Inhibitors

The Last Word—3 Big Predictions

Legal Disclaimer

Appendix—Checkpoint Inhibitors Development Pipeline Summaries

Pipeline Analysis—CTLA-4/CAIX/GITR Segment, Products in Development

Pipeline Analysis—CTLA-4/CAIX/GITR Segment, Products in Development (continued)

Pipeline Analysis—CTLA-4/CAIX/GITR Segment, Products in Development (continued)

Pipeline Analysis—CTLA-4/CAIX/GITR Segment, Products in Development (continued)

Pipeline Analysis—CTLA-4/CAIX/GITR Segment, Products in Development (continued)

Pipeline Analysis—LAG-3 Products in Development

Pipeline Analysis—LAG-3 Products in Development (continued)

Pipeline Analysis—LAG-3 Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—PD-1/PD-L1 Segment, Products in Development (continued)

Pipeline Analysis—TIM-3 (T-cell immunoglobin and mucin domain 3) Segment, Products in Development

Pipeline Analysis—TIM-3 (T-cell immunoglobin and mucin domain 3) Segment, Products in Development (continued)

Pipeline Analysis—TIM-3 (T-cell immunoglobin and mucin domain 3) Segment, Products in Development (continued)

The Frost & Sullivan Story

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Request Sample
Related Research

Payment Reforms and Digital Technologies to Drive Future of Hospital at Home Care Models

Release Date: 28-Apr-21
Region: Global

Innovative Business Models Unleash Growth Opportunities in the MedTech Industry

Release Date: 23-Mar-21
Region: North America

GROWTH OPPORTUNITIES IN CELL AND GENE THERAPIES, RETINAL DISEASES, DRUG DELIVERY PLATFORMS, PLANT-BASED DRUGS, CARDIAC HEALTH, AI-BASED DEVICES, COMPUTATION METHODS, AND CULTURED MILK

Release Date: 19-Mar-21
Region: Global

Innovative Public-Private Partnerships Transforming the KSA Healthcare Industry, Outlook 2021

Release Date: 9-Mar-21
Region: South Asia, Middle East & North Africa

Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021

Release Date: 2-Mar-21
Region: North America

INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, ADVANCED DIAGNOSTICS, AND DIGITAL THERAPY PLATFORMS

Release Date: 26-Feb-21
Region: Global

GROWTH OPPORTUNITIES IN TARGETED CANCER THERAPY & CANCER DIAGNOSTICS, VIRAL VECTORS, MULTIPLE DISEASES, RETINAL DISEASES, AND COSMECEUTICALS

Release Date: 19-Feb-21
Region: Global

Transformational Growth Powering the Digital Operating Room Market in the United States and Western Europe

Release Date: 8-Feb-21
Region: North America

INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, POINT-OF CARE DIAGNOSTICS, AND NOVEL IMPLANT PLATFORMS

Release Date: 29-Jan-21
Region: Global

Artificial Intelligence Powering the Global Medical Imaging Market

Release Date: 27-Jan-21
Region: North America
CCBot/2.0 (https://commoncrawl.org/faq/)
Popular Topics

energy storage market

commercial aviation market

neurology devices market

commercial lighting market

heavy truck market

digital signage market

offshore market

food preservatives market

photovoltaic market

power electronics market

×

Price:
Actual Price:
Our price is lower than the manufacturer's "minimum advertised price." As a result, we cannot show you the price in catalog or the product page.

You have no obligation to purchase the product once you know the price. You can simply remove the item from your cart.
Our price is lower than the manufacturer's "minimum advertised price." As a result, we cannot show you the price in catalog or the product page.

You have no obligation to purchase the product once you know the price. You can simply remove the item from your cart.
our company
  • Frost.com
  • About Frost & Sullivan
  • Privacy Policy
  • Sitemap
  • FAQ
  • Return Policy
  • Disclaimer
  • How to Shop
  • Contact Us
Global presence
  • North America
  • Latin America
  • Middle East
  • Europe, Israel & Africa
  • Asia Pacific
  • South Asia
Global locations
connect with us
Sign up for newsletter and updates
Close
Close
Close
Close
Close
Close
Close
Research Deliverables
  • Market Research
  • Technology Research
  • Mega Trends Research
  • Tracker
  • Strategic Forecasting
  • Market Outlet Research
  • Customer Research
  • Database and Economic
  • Analyst Briefings
Industries
  • Aerospace Market Research
  • Defence Market Research
  • Security Market Research
  • Automative Market Research
  • Transportation Market Research
  • Chemicals Market Research
  • Materials Market Research
  • Energy Market Research
  • Enviornment Market Research
  • Food Market Research
  • Agriculture Market Research
  • Healthcare Market Research
  • Industrial Automation Market Research
  • Information Technology Market Research
  • Telecom Market Research
  • Media Market Research
  • Metals and Minerals Market Research
  • Personal Protective Equipment Research
  • Test and Measurement Market Research
Themes
  • Artificial Intelligence Market Research
  • IIOT Market Research
  • IOT Market Research
  • Big Data Analytics Market Research
  • Robotics Market Research
  • Brexit
  • Femtech Market Research
  • Fintech
© 2021 Frost & Sullivan. All Rights Reserved.

Login

 
Forgot Your Password?
loading please wait

Don't have an account? Create One!


Forgot Your Password?

Enter your Email Address here to receive a link to change password.

loading please wait

New User? Sign Up

If you are an existing frost.com user, please register using the same email for seamless access

Please Fill Recaptcha To Continue
loading please wait

Already have an account? Login!


Please Enter your twitter email

loading please wait
Already have an account? Login!

Connect With LinkedIn

Use your Linkedin account to login or register within our store.You're just one click away.